NPCE
NeuroPace Inc

315
Loading...
Loading...
News
all
press releases
NeuroPace to Participate in Upcoming Healthcare Conferences
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in two healthcare...
Business Wire·14d ago
News Placeholder
More News
News Placeholder
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates
NeuroPace (NPCE) delivered earnings and revenue surprises of -8.33% and +0.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +28.57% and +10.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates
Orthofix (OFIX) delivered earnings and revenue surprises of +225.00% and +3.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of +76.92% and +7.52%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
Zacks·4mo ago
News Placeholder
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Zacks·4mo ago
News Placeholder
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Recent Price Trend in NeuroPace (NPCE) is Your Friend, Here's Why
Zacks·4mo ago

Latest NPCE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.